We report the case of a 14-year-old female with acute promyelocytic leukemia who developed symptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA).
symptomatic cardiomyopathy
daunomycin
symptomatic cardiomyopathy
ATRA
symptomatic cardiomyopathy
all-trans retinoic acid